IDEXX Laboratories, Inc. I1DX34.SA Stock
IDEXX Laboratories, Inc. Price Chart
IDEXX Laboratories, Inc. I1DX34.SA Financial and Trading Overview
IDEXX Laboratories, Inc. stock price | 511 BRL |
Previous Close | 456.04 BRL |
Open | 0 BRL |
Bid | 462.5 BRL x N/A |
Ask | 0 BRL x N/A |
Day's Range | 0 - 0 BRL |
52 Week Range | 0 - 509.99 BRL |
Volume | 0 BRL |
Avg. Volume | 2 BRL |
Market Cap | 189.19B BRL |
Beta (5Y Monthly) | 1.191901 |
PE Ratio (TTM) | 55.887257 |
EPS (TTM) | 10.27 BRL |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
I1DX34.SA Valuation Measures
Enterprise Value | 39.06B BRL |
Trailing P/E | 55.887257 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 55.143173 |
Price/Book (mrq) | 45.00543 |
Enterprise Value/Revenue | 11.385 |
Enterprise Value/EBITDA | 37.397 |
Trading Information
IDEXX Laboratories, Inc. Stock Price History
Beta (5Y Monthly) | 1.191901 |
52-Week Change | 35.48% |
S&P500 52-Week Change | 20.43% |
52 Week High | 509.99 BRL |
52 Week Low | 0 BRL |
50-Day Moving Average | 477.09 BRL |
200-Day Moving Average | 449.07 BRL |
I1DX34.SA Share Statistics
Avg. Volume (3 month) | 2 BRL |
Avg. Daily Volume (10-Days) | 2 BRL |
Shares Outstanding | 414.86M |
Float | 82.16M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 20.37% |
Operating Margin (ttm) | 27.12% |
Gross Margin | 59.70% |
EBITDA Margin | 30.44% |
Management Effectiveness
Return on Assets (ttm) | 21.54% |
Return on Equity (ttm) | 94.42% |
Income Statement
Revenue (ttm) | 3.43B BRL |
Revenue Per Share (ttm) | 41.2 BRL |
Quarterly Revenue Growth (yoy) | 7.59% |
Gross Profit (ttm) | 2B BRL |
EBITDA | 1.04B BRL |
Net Income Avi to Common (ttm) | 699.18M BRL |
Diluted EPS (ttm) | 8.16 |
Quarterly Earnings Growth (yoy) | 10.40% |
Balance Sheet
Total Cash (mrq) | 111.37M BRL |
Total Cash Per Share (mrq) | 1.34 BRL |
Total Debt (mrq) | 1.32B BRL |
Total Debt/Equity (mrq) | 156.96 BRL |
Current Ratio (mrq) | 1.079 |
Book Value Per Share (mrq) | 10.133 |
Cash Flow Statement
Operating Cash Flow (ttm) | 612.19M BRL |
Levered Free Cash Flow (ttm) | 398.99M BRL |
Profile of IDEXX Laboratories, Inc.
Country | Brazil |
State | ME |
City | Westbrook |
Address | One IDEXX Drive |
ZIP | 04092 |
Phone | 207 556 0300 |
Website | https://www.idexx.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 10780 |
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Q&A For IDEXX Laboratories, Inc. Stock
What is a current I1DX34.SA stock price?
IDEXX Laboratories, Inc. I1DX34.SA stock price today per share is 511 BRL.
How to purchase IDEXX Laboratories, Inc. stock?
You can buy I1DX34.SA shares on the São Paulo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IDEXX Laboratories, Inc.?
The stock symbol or ticker of IDEXX Laboratories, Inc. is I1DX34.SA.
Which industry does the IDEXX Laboratories, Inc. company belong to?
The IDEXX Laboratories, Inc. industry is Diagnostics & Research.
How many shares does IDEXX Laboratories, Inc. have in circulation?
The max supply of IDEXX Laboratories, Inc. shares is 415.27M.
What is IDEXX Laboratories, Inc. Price to Earnings Ratio (PE Ratio)?
IDEXX Laboratories, Inc. PE Ratio is 49.75657000 now.
What was IDEXX Laboratories, Inc. earnings per share over the trailing 12 months (TTM)?
IDEXX Laboratories, Inc. EPS is 10.27 BRL over the trailing 12 months.
Which sector does the IDEXX Laboratories, Inc. company belong to?
The IDEXX Laboratories, Inc. sector is Healthcare.